K Späthe
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 4
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 3
- Obstetrics and Gynecology top 5%
- Immunology and Allergy top 10%
- Hematology top 10%
-
- Peptidase Inhibition and Analysis 3
- Lung Cancer Research Studies 2
- PARP inhibition in cancer therapy 2
- Pancreatic and Hepatic Oncology Research 1
-
- Intraperitoneal and Appendiceal Malignancies 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Barbara SchmalfeldtWalther KuhnManfred SchmittUrsula BergerRafael FridmanDieter PrechtelErnst LengyelH. Graeff
- Partner nations
- GermanyUnited States
In The Last Decade
K Späthe
9 papers receiving 781 citations
Peers
Comparison fields: 5 of 76
- Reproductive Medicine 275
- Cancer Research 298
- Obstetrics and Gynecology 124
- Immunology and Allergy 72
- Hematology 114
Countries citing papers authored by K Späthe
This map shows the geographic impact of K Späthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Späthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Späthe more than expected).
Fields of papers citing papers by K Späthe
This network shows the impact of papers produced by K Späthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Späthe. The network helps show where K Späthe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K Späthe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 58 | |
| 2 | 2003 | 2 | |
| 3 | 2001 | 100 | |
| 4 | 2001 | 151 | |
| 5 | Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. | 2001 | 300 |
| 6 | 1999 | 110 | |
| 7 | 1998 | 45 | |
| 8 | Disease-adapted relapse therapy for ovarian cancer: results of a prospective study. | 1998 | 20 |
| 9 | 1998 | 14 |
About K Späthe
K Späthe is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Obstetrics and Gynecology and Biotechnology, having authored 9 papers that have together received 800 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Peptidase Inhibition and Analysis (3 papers), Protease and Inhibitor Mechanisms (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Lung Cancer Research Studies (2 papers), PARP inhibition in cancer therapy (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Reproductive Medicine (275 citations), Cancer Research (298 citations), Obstetrics and Gynecology (124 citations), Immunology and Allergy (72 citations) and Hematology (114 citations). K Späthe has collaborated with scholars based in Germany and United States. Frequent co-authors include Barbara Schmalfeldt, Walther Kuhn, Manfred Schmitt, Ursula Berger, Rafael Fridman, Dieter Prechtel, Ernst Lengyel, H. Graeff, Kurt Ulm and G. Florack. Their work appears in journals such as Cancer, British Journal of Cancer, Gynecologic Oncology, Supportive Care in Cancer and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.